source
- J&J advances IBD combo to Phase 3 despite Phase 2 setbacksJohnson & Johnson said it will advance its experimental inflammatory bowel disease therapy, JNJ-4804, into Phase 3 trials even though the drug failed to meet primary endpoints in two Phase 2 studie…
- Parsley Health joins nationwide insurance networks, expanding access to its primary-care modelParsley Health, a decade-old primary-care startup that originally operated on a cash-pay model, announced that it is now in-network with insurers across the United States. The move marks a shift f…